Nuveen Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1,247,261
| Closed | -$5.24M | – | 3363 |
|
2023
Q1 | $5.24M | Sell |
1,247,261
-56,291
| -4% | -$236K | ﹤0.01% | 1860 |
|
2022
Q4 | $7.83M | Sell |
1,303,552
-49,957
| -4% | -$300K | ﹤0.01% | 1648 |
|
2022
Q3 | $7.88M | Sell |
1,353,509
-396,684
| -23% | -$2.31M | ﹤0.01% | 1630 |
|
2022
Q2 | $10.4M | Buy |
+1,750,193
| New | +$10.4M | ﹤0.01% | 1476 |
|
2016
Q2 | – | Sell |
-1,504
| Closed | -$8 | – | 1433 |
|
2016
Q1 | $8 | Hold |
1,504
| – | – | ﹤0.01% | 1357 |
|
2015
Q4 | $19 | Buy |
1,504
+343
| +30% | +$4 | ﹤0.01% | 1402 |
|
2015
Q3 | $17 | Hold |
1,161
| – | – | ﹤0.01% | 1430 |
|
2015
Q2 | $23 | Hold |
1,161
| – | – | ﹤0.01% | 1471 |
|
2015
Q1 | $21K | Buy |
1,161
+121
| +12% | +$2.19K | ﹤0.01% | 1488 |
|
2014
Q4 | $25K | Sell |
1,040
-40
| -4% | -$962 | ﹤0.01% | 1524 |
|
2014
Q3 | $26K | Hold |
1,080
| – | – | ﹤0.01% | 1500 |
|
2014
Q2 | $30K | Hold |
1,080
| – | – | ﹤0.01% | 1530 |
|
2014
Q1 | $37K | Hold |
1,080
| – | – | ﹤0.01% | 1518 |
|
2013
Q4 | $21K | Buy |
+1,080
| New | +$21K | ﹤0.01% | 1485 |
|